Study of impacts of different evaluation criteria on gamma pass rates in VMAT QA using MatriXX and EPID

[1] Verbakel WF, Cuijpers J P, Hoffmans D, et al. Volumetric intensity-modulated arc therapy versus conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study. Int J Radiat Oncol Biol Phys. 2009;74(1):252–259.10.1016/j.ijrobp.2008.12.03319362244Search in Google Scholar

[2] Wolff D, Stieler F, Welzel G, et al. Volumetric modulated arc therapy (VMAT) versus serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol. 2009;93(2):226–233.10.1016/j.radonc.2009.08.01119765846Open DOISearch in Google Scholar

[3] Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys. 2008;35(1):310-317.10.1118/1.281873818293586Open DOISearch in Google Scholar

[4] Bedford JL, Warrington AP. Commissioning of volumetric modulated arc therapy (VMAT). Int J Radiat Oncol Biol Phys. 2009;73:537-545.10.1016/j.ijrobp.2008.08.05519147018Search in Google Scholar

[5] Tatsumi D, Hosono MN, Nakada R, et al. Direct impact analysis of multi-leaf collimator leaf position errors on dose distributions in volumetric modulated arc therapy: a pass rate calculation between measured planar doses with and without the position errors. Phys Med Biol. 2011;56(20):237-246.10.1088/0031-9155/56/20/N0321965281Open DOISearch in Google Scholar

[6] Pardo Montero J, Fenwick JD. The effect of different control point sampling sequences on convergence of VMAT inverse planning Phys Med Biol. 2011;56(8):2569-2583.10.1088/0031-9155/56/8/01521444974Search in Google Scholar

[7] Iftimia I, Cirino ET, Xiong L, Mower HW. Quality assurance methodology for Varian RapidArc treatment plans. J Appl Clin Med Phys. 2010;11(4):316410.1120/jacmp.v11i4.3164572040521081873Open DOISearch in Google Scholar

[8] Chandraraj V, Stathakis S, Manickam R, et al. Consistency and reproducibility of the VMAT plan delivery using three independent validation methods. J Appl Clin Med Phys. 2010;12(1):3373.Search in Google Scholar

[9] Hussein M, Adams EJ, Jordan TJ, et al. A critical evaluation of the PTW 2D-ARRAY seven29 and OCTAVIUS II phantom for IMRT and VMAT verification. J Appl Clin Med Phys. 2013;14(6):4460.10.1120/jacmp.v14i6.4460571463924257288Search in Google Scholar

[10] Zhu J, Chen L, Jin G. A comparison of VMAT dosimetric verifications between fixed and rotating gantry positions. Phys Med Biol. 2013;58(15):1315-1322.10.1088/0031-9155/58/5/131523388132Search in Google Scholar

[11] Wolfsberger LD, Wagar M, Nitsch P, et al. Angular dose dependence of Matrixx TM and its calibration J Appl Clin Med Phys. 2010;11(1): 241-251.10.1120/jacmp.v11i1.3057571977620160692Open DOISearch in Google Scholar

[12] Herzen J, Todorovic M, Cremers F, et al. Dosimetric evaluation of a 2D pixel ionization chamber for implementation in clinical routine Phys Med Biol. 2007;52(4):1197-1208.10.1088/0031-9155/52/4/02317264380Search in Google Scholar

[13] Li JG, Yan G, Liu C. Comparison of two commercial detector arrays for IMRT quality assurance J Appl Clin Med Phys. 2009;10(2):62-74.10.1120/jacmp.v13i6.4017571854423149795Open DOISearch in Google Scholar

[14] Han Z, Ng SK, Bhagwat MS, et al. Evaluation of MatriXX for IMRT and VMAT dose verifications in peripheral dose regions. Med Phys. 2010;37(7):3704-3714.10.1118/1.345570720831078Open DOISearch in Google Scholar

[15] Wiezorek T, Banz N, Schwedas M, et al. Dosimetric quality assurance for intensity-modulated radiotherapy feasibility study for a filmless approach. Strahlenther Onkol. 2005;181(7):468-474.10.1007/s00066-005-1381-z15995841Search in Google Scholar

[16] Chandraraj V, Stathakis S, Manickam R, et al. Comparison of four commercial devices for RapidArc and sliding window IMRT QA. J Appl Clin Med Phys. 2011;12(2):338-349.10.1120/jacmp.v12i2.3367571869121587184Open DOISearch in Google Scholar

[17] Shimohigashi Y, Araki F, Tominaga H, et al. Angular dependence correction of MatriXX and its application to composite dose verification. J Appl Clin Med Phys. 2012;13(5):81-96.10.1120/jacmp.v13i5.3856571824422955651Search in Google Scholar

[18] Boggula R, Birkner M, Lohr F, et al. Evaluation of a 2D detector array for patient-specific VMAT QA with different setups. Phys Med Biol. 2011l56(22):7163-7177.10.1088/0031-9155/56/22/01122025217Search in Google Scholar

[19] Bakhtiari M, Kumaraswamy L, Bailey DW, et al. Using an EPID for patient-specific VMAT quality assurance Using an EPID for patient-specific VMAT quality assurance. Med Phys. 2011;38(3):1366-73.10.1118/1.355292521520847Open DOISearch in Google Scholar

[20] Iori M, Cagni E, Paiusco M, et al. Dosimetric verification of IMAT delivery with a conventional EPID system and a commercial portal dose image prediction tool. Med Phys. 2010;37(1):377-390.10.1118/1.327110720175500Search in Google Scholar

[21] Sharma DS, Mhatre V, Heigrujam M, et al. Portal dosimetry for pretreatment verification of IMRT plan : a comparison with 2D ion chamber array. J Appl Clin Med Phys. 2010;11(4):3268.10.1120/jacmp.v11i4.3268572040321081884Search in Google Scholar

[22] Low DA, Harms WB, Mutic S, Purdy JA. A technique for the quantitative evaluation of dose distributions. Med Phys. 1998;25(5):656-661.10.1118/1.5982489608475Search in Google Scholar

[23] Bailey DW, Nelms BE, Attwood K, et al. Statistical variability and confidence intervals for planar dose QA pass rates. Med Phys. 2011;38(11):6053-6064.10.1118/1.365169522047370Search in Google Scholar

[24] Low DA, Dempsey JF. Evaluation of the gamma dose distribution comparison method. Med Phys. 2003;30(9):2455-2464.10.1118/1.159871114528967Search in Google Scholar

[25] Das IJ, Ding GX, Ahnesjö A. Small fields: nonequilibrium radiation dosimetry. Med Phys. 2008;35(1):206-215.10.1118/1.281535618293576Search in Google Scholar

[26] Bailey DW, Kumaraswamy L, Bakhtiari M, et al. EPID dosimetry for pretreatment quality assurance with two commercial systems. J Appl Clin Med Phys. 2012;13(4):3736.10.1120/jacmp.v13i4.3736571651022766944Search in Google Scholar

[27] Wagner D, Vorwerk H. Two years experience with quality assurance protocol for patient related Rapid Arc treatment plan verification using a two dimensional ionization chamber array. Radiat Oncol. 2011;6(1):21.10.1186/1748-717X-6-21304912021342509Search in Google Scholar

[28] Mans A, Remeijer P, Olaciregui-Ruiz I, et al. 3D dosimetric verification of volumetric-modulated arc therapy by portal dosimetry. Radiother Oncol. 2010;94:181-187.10.1016/j.radonc.2009.12.02020089323Search in Google Scholar

[29] van Elmpt W, Nijsten S, Dekker AL, et al. Treatment verification in the presence of inhomogeneities using EPID-based three dimensional dose reconstruction Med. Phys. 2007;34(7):2816-2826.10.1118/1.274277817821989Open DOISearch in Google Scholar

[30] Boggula R, Lorenz F, Mueller L, et al. Experimental validation of a commercial 3D dose verification system for intensity-modulated arc therapies. Phys Med Biol. 2010;55(19):5619-5633.10.1088/0031-9155/55/19/00120826904Search in Google Scholar

[31] Mancuso GM, Fontenot JD, Gibbons JP, parker BC. Comparison of action levels for patient-specific quality assurance of intensity modulated radiation therapy and volumetric modulated arc therapy treatments. Med Phys. 2012;39(7):4378-4385.10.1118/1.472973822830770Open DOISearch in Google Scholar